Drug profile · INN
benzathine benzylpenicillin
BICILLIN L-A
benzathine benzylpenicillin (BICILLIN L-A) is a bacterial penicillin-binding protein inhibitor. Associated with Pfizer Australia Pty Ltd.
TGA: approved
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — benzathine benzylpenicillin
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.81
Quick answer
benzathine benzylpenicillin (BICILLIN L-A) is a bacterial penicillin-binding protein inhibitor. Associated with Pfizer Australia Pty Ltd.
Key facts
INN benzathine benzylpenicillin
Brand BICILLIN L-A
Mechanism Bacterial penicillin-binding protein inhibitor
Target Bacterial penicillin-binding protein
Originator Pfizer Australia Pty Ltd
Mechanism of action
Bacterial penicillin-binding protein inhibitor
Primary target: Bacterial penicillin-binding protein
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is benzathine benzylpenicillin?
benzathine benzylpenicillin (BICILLIN L-A) is a bacterial penicillin-binding protein inhibitor. Associated with Pfizer Australia Pty Ltd.
What is the brand name for benzathine benzylpenicillin?
BICILLIN L-A is a marketed brand name for benzathine benzylpenicillin. Check FDA Drugs@FDA for the current US label holder and prescribing information.